This company has been marked as potentially delisted and may not be actively trading. Digirad (DRAD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DRAD vs. NRXS, VRAYQ, VIVE, ELMD, QTI, MRM, SLGL, TMDIF, UG, and POCIShould you be buying Digirad stock or one of its competitors? The main competitors of Digirad include NeurAxis (NRXS), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), QT Imaging (QTI), MEDIROM Healthcare Technologies (MRM), Sol-Gel Technologies (SLGL), Titan Medical (TMDIF), United-Guardian (UG), and Precision Optics (POCI). These companies are all part of the "medical" sector. Digirad vs. Its Competitors NeurAxis ViewRay Viveve Medical Electromed QT Imaging MEDIROM Healthcare Technologies Sol-Gel Technologies Titan Medical United-Guardian Precision Optics Digirad (NASDAQ:DRAD) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation. Which has higher valuation & earnings, DRAD or NRXS? Digirad has higher revenue and earnings than NeurAxis. Digirad is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDigirad$114.18M0.08-$4.63M-$0.35-5.77NeurAxis$2.93M6.05-$14.63M-$1.19-2.07 Is DRAD or NRXS more profitable? Digirad has a net margin of -5.32% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Digirad's return on equity.Company Net Margins Return on Equity Return on Assets Digirad-5.32% -3.75% -0.85% NeurAxis -492.76%N/A -641.25% Which has more volatility and risk, DRAD or NRXS? Digirad has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 3.1, suggesting that its stock price is 210% more volatile than the S&P 500. Do insiders & institutionals believe in DRAD or NRXS? 11.4% of Digirad shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 12.5% of Digirad shares are owned by insiders. Comparatively, 26.4% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts recommend DRAD or NRXS? NeurAxis has a consensus target price of $7.00, indicating a potential upside of 184.55%. Given NeurAxis' stronger consensus rating and higher probable upside, analysts clearly believe NeurAxis is more favorable than Digirad.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Digirad 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeurAxis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer DRAD or NRXS? In the previous week, Digirad's average media sentiment score of 0.00 equaled NeurAxis'average media sentiment score. Company Overall Sentiment Digirad Neutral NeurAxis Neutral SummaryNeurAxis beats Digirad on 8 of the 14 factors compared between the two stocks. Get Digirad News Delivered to You Automatically Sign up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRAD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRAD vs. The Competition Export to ExcelMetricDigiradElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.62M$30.35M$5.44B$9.61BDividend Yield83.65%N/A4.61%4.14%P/E Ratio-0.642.7829.7624.84Price / Sales0.08165.52449.1298.65Price / Cash0.6941.3636.4258.36Price / Book0.201.838.185.64Net Income-$4.63M-$2.66M$3.26B$265.68M Digirad Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRADDigiradN/A$2.02+0.5%N/A-54.1%$9.62M$114.18M-0.64618NRXSNeurAxis2.8456 of 5 stars$2.53+0.4%$7.00+176.6%-13.7%$18.26M$2.93M-1.3819Upcoming EarningsGap UpVRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300High Trading VolumeVIVEViveve MedicalN/A$0.00flatN/A-66.7%$1K$6.83M0.0070ELMDElectromed2.1512 of 5 stars$18.61-0.1%$33.50+80.0%+24.7%$156.06M$61.44M24.81160Positive NewsQTIQT ImagingN/A$1.75-7.9%N/A+287.4%$47.48M$4.00M0.00N/ANews CoveragePositive NewsMRMMEDIROM Healthcare Technologies0.6121 of 5 stars$1.33-0.4%N/A-6.6%$37.61M$8.30B0.00480News CoverageShort Interest ↑Gap UpSLGLSol-Gel Technologies1.7858 of 5 stars$13.75+2.5%$40.00+190.9%+327.0%$37.38M$11.54M-2.9350Upcoming EarningsGap UpTMDIFTitan MedicalN/A$0.33-7.1%N/A+880.4%$37.07M$17.63M-0.2650UGUnited-Guardian3.0052 of 5 stars$8.02-0.5%N/A-28.8%$37.04M$12.18M12.7320News CoverageEarnings ReportPOCIPrecision Optics0.1718 of 5 stars$4.66-2.1%N/A-17.3%$36.47M$19.10M-5.2480Gap Down Related Companies and Tools Related Companies NeurAxis Competitors ViewRay Competitors Viveve Medical Competitors Electromed Competitors QT Imaging Competitors MEDIROM Healthcare Technologies Competitors Sol-Gel Technologies Competitors Titan Medical Competitors United-Guardian Competitors Precision Optics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRAD) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
